A detailed history of Profund Advisors LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 20,416 shares of REPL stock, worth $255,200. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,416
Holding current value
$255,200
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.09 - $11.23 $165,165 - $229,271
20,416 New
20,416 $223,000
Q1 2024

May 08, 2024

BUY
$6.87 - $9.31 $165,457 - $224,222
24,084 Added 32.44%
98,317 $803,000
Q4 2023

Feb 14, 2024

BUY
$6.75 - $16.18 $288,063 - $690,497
42,676 Added 135.23%
74,233 $625,000
Q3 2023

Nov 13, 2023

BUY
$15.96 - $22.18 $80,518 - $111,898
5,045 Added 19.03%
31,557 $539,000
Q2 2023

Aug 10, 2023

SELL
$15.65 - $24.1 $215,829 - $332,363
-13,791 Reduced 34.22%
26,512 $615,000
Q1 2023

May 11, 2023

BUY
$17.48 - $29.09 $704,496 - $1.17 Million
40,303 New
40,303 $711,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.